Accellix is a company focused on creating a rapid, easy-to-use, automated cell phenotyping platform for point-of-need environments, with a specific emphasis on cell therapy. They offer next-generation analytical capabilities to measure critical quality attributes throughout the manufacturing process and release of cell therapy products. Accellix aims to automate the GMP cell phenotyping process with their Accellix Platform, integrating sample preparation, flow cytometry, and data analysis directly into manufacturing suites. The company's interdisciplinary team includes skilled biologists, engineers, mathematicians, and technicians with expertise in cell therapy and immunotherapy. Accellix's mission is to establish a new standard for quality control in the cell and gene therapy industry by providing compact, automated, and easy-to-use flow cytometry capabilities that integrate seamlessly into manufacturing workflows.